Fractyl Health, Inc. Common Stock

GUTSNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
0.86 USD
↘ 0.09 (9.79%)AT CLOSE (11:59 AM EDT)
0.85
↘ 0.01 (0.77%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
0.85
↘ 0.01 (0.77%)
🔴Market: CLOSED
Open?$0.93
High?$0.93
Low?$0.83
Prev. Close?$0.95
Volume?2.8M
Avg. Volume?2.1M
VWAP?$0.87
Rel. Volume?1.32x
Bid / Ask
Bid?$0.72 × 100
Ask?$0.98 × 100
Spread?$0.26
Midpoint?$0.85
Valuation & Ratios
Market Cap?136.4M
Shares Out?158.6M
Float?74.4M
Float %?54.3%
P/E Ratio?N/A
P/B Ratio?6.38
EPS?-$0.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Themes
Biotech - Drug Development›Metabolic & CardiometabolicMedical Devices & HealthTech›Surgical & Robotic Systems
Employees
73
Market Cap
136.5M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.fractyl.com
Listed
2024-02-02
Address
3 VAN DE GRAAFF DRIVE
BURLINGTON, MA 01803
Phone: 781-902-8800
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.28Strong
Quick Ratio?4.28Strong
Cash Ratio?4.10Strong
Debt/Equity?1.41Moderate
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A▾
P/B?
6.38FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-1.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-505.2%WEAK▾
ROA?
-108.7%WEAK▾
Cash Flow & Enterprise
FCF?$-87835000
Enterprise Value?$103.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist